Search

Traditional medical practice in the world has maintained its popularity in spite of the challenges of the rapid development of modern medicine. The World Health Organization observed that 80% of world population still rely on traditional practices of special cultural heritages.In Asia, the traditional practices include mainly that of the Middle East, India and China. The 3000 years of development in the three different regions has resulted in cross-cultural influences and exchanges, particularly revealed in the rich collections of medicinal herbs.Ayurveda medicine has well maintained its traditional philosophy and practice. It has enjoyed very substantial governmental support on the national level and has remained popular. Traditional Chinese Medicine, likewise, has kept its popularity and vibrance. However, with the ever advancing modern medicine which is giving efficient acute care and specific solutions to known target areas of clinical concern, are unavoidable obstacles to an integrative practice.Besides India, China is the only country in the world where Traditional Medicine is still playing a major role in national health care. During the COVID-19 pandemic both Ayurveda and Chinese Medicine practitioners tried hard to contribute by offering integrative treatment to the infected patients. They were getting a lot of national and professional endorsements. One would speculate that with this unknown virus and diverse clinical presentations, a better integrative program would be able to provide better outcome.On the prevention side, medicinal herbs are expected to be able to boost up the innate immunity of the individual so that infection could be better resisted.Given the similarities between the Indian and Chinese Systems of traditional practice, it is suggested that Ayurveda and Chinese Medicine could develop a joint mission with combined efforts, to collaborate in research and trials, with the aim of consolidating Integrative Practice. This article concentrates on the Indian and Chinese areas of traditional practice, viz. Ayurveda and Chinese Medicine.

Severe COVID-19 infection requiring oxygen support is reported to have high mortality. Chest Severity Score evaluated through CT scan has a predictive value about future outcomes in such cases. Score value ∼18 is predicted to have poor outcomes. We are presenting here a case of severe COVID-19 with all predictors suggestive of a bad prognosis including IL-6, D-Dimer, Ferritin and CRP in addition to 18/25 Chest Severity Score. Initially treated under ICU care at a tertiary care COVID hospital for about 14 days, the patient was intervened with Ayurveda on his own insistence seeing the unsatisfactory improvements. Ayurveda intervention for 19 days along with standard ICU care resulted in complete clinical recovery of the patient besides the correction of biomarker levels. Rapid clinical and biochemical correction in this severe COVID-19 case against all odds is highly significant and warrants an urgent search for possibility of instituting the integrative management strategies for all those treated in an allopathic facility. This case also advocates an early institution of Ayurveda interventions in COVID-19 in order to prevent deterioration leading to complications.